Risk factors and clinical preservation of acute primary HIV infection in India

被引:83
作者
Bollinger, RC
Brookmeyer, RS
Mehendale, SM
Paranjape, RS
Shepherd, ME
Gadkari, DA
Quinn, TC
机构
[1] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DIV INFECT DIS,BALTIMORE,MD
[2] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOSTAT,BALTIMORE,MD 21205
[3] NATL AIDS RES INST,PUNE,MAHARASHTRA,INDIA
[4] NIAID,NIH,BETHESDA,MD 20892
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1997年 / 278卷 / 23期
关键词
D O I
10.1001/jama.278.23.2085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-Most previous studies of clinical presentation and risk factors in early human immunodeficiency virus (HIV) infection have relied on retrospective analyses and referred seroconverters, and thus were subject to possible bias. Objectives.-To apply a method based on measurement of prevalent HIV-1 p24 antigenemia for identification of risk factors for newly acquired HIV infection and to describe the signs and symptoms of acute HIV infection. Design and Setting.-Nested case-control study in Pune, India. Participants.-HIV antibody-negative persons attending 2 sexually transmitted disease (STD) clinics between May 1993 and June 1996. Outcome Measures.-Prevalent p24 antigenemia, risk factors for HIV infection, and clinical symptoms of acute primary HIV infection. Results.-Of 3874 HIV antibody-negative persons tested, 58 (1.5%) were p24 antigen positive at initial presentation to the clinics. Unprotected sexual contact with a commercial sex worker (CSW) was reported by 39 (77%) of the 51 p24 antigenemic men, compared with 131 (51%) of 255 control men (adjusted odds ratio [AOR], 3.4; 95% confidence interval [CI], 1.2-9.6; P=.02). The presence of an active genital ulcer at the time of screening was found in 46 (79%) of the 58 p24 antigenemic men and women, compared with 137 (47%) of the 290 control subjects (AOR, 4.2; 95% CI, 2.0-9.0; P<.001). Signs and symptoms independently associated with p24 antigenemia in HIV antibody-seronegative persons included fever, which was reported by 28 (48%) of the 58 p24 antigenemic subjects, but only 52 (18%) of the 290 control subjects (AOR, 4.7; 95% CI, 2.4-9.0; P<.001). Joint pain was reported by 10% of subjects recently HIV infected, compared with 2% of the control subjects (AOR, 6.5; 95% CI, 1.7-24.8; P=.006), Night sweats were reported by 9% of the p24 antigenemic, but only 1% of the control subjects (AOR, 9.1; 95% CI, 1.7-47.6; P=.009), Overall, fever, joint pain, and/or night sweats were reported in 27 (47%) of the 58 subjects with recent HIV infection. Conclusions.-This systematic case-control study of p24 antigen screening in HIV-seronegative patients attending STD clinics in India identified unprotected sex with a CSW and a genital ulcer as independent risk factors associated with newly acquired HIV infection. In addition, p24 antigen positivity identified recent fever, night sweats, and arthralgias as symptoms that may be predictive of recent HIV infection, In a study of patients attending STD clinics in India, screening for p24 antigen in HIV antibody-negative persons was found to be a reliable and effective research method for determining recent risk behavior and identifying clinical signs of acute primary HIV infection.
引用
收藏
页码:2085 / 2089
页数:5
相关论文
共 15 条
  • [1] THE HUMAN-IMMUNODEFICIENCY-VIRUS EPIDEMIC IN INDIA - CURRENT MAGNITUDE AND FUTURE PROJECTIONS
    BOLLINGER, RC
    TRIPATHY, SP
    QUINN, TC
    [J]. MEDICINE, 1995, 74 (02) : 97 - 106
  • [2] THE AIDS EPIDEMIC IN INDIA - A NEW METHOD FOR ESTIMATING CURRENT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INCIDENCE RATES
    BROOKMEYER, R
    QUINN, T
    SHEPHARD, M
    MEHENDALE, S
    RODRIGUES, J
    BOLLINGER, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (07) : 709 - 713
  • [3] *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P19
  • [4] Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1
  • [5] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION
    CLARK, SJ
    SAAG, MS
    DECKER, WD
    CAMPBELLHILL, S
    ROBERSON, JL
    VELDKAMP, PJ
    KAPPES, JC
    HAHN, BH
    SHAW, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 954 - 960
  • [6] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964
  • [7] FOX R, 1987, AIDS, V1, P35
  • [8] TEMPORAL ASSOCIATION OF CELLULAR IMMUNE-RESPONSES WITH THE INITIAL CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNDROME
    KOUP, RA
    SAFRIT, JT
    CAO, YZ
    ANDREWS, CA
    MCLEOD, G
    BORKOWSKY, W
    FARTHING, C
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4650 - 4655
  • [9] INCIDENCE AND PREDICTORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION IN PATIENTS ATTENDING SEXUALLY-TRANSMITTED DISEASE CLINICS IN INDIA
    MEHENDALE, SM
    RODRIGUES, JJ
    BROOKMEYER, RS
    GANGAKHEDKAR, RR
    DIVEKAR, AD
    GOKHALE, MR
    RISBUD, AR
    PARANJAPE, RS
    SHEPHERD, ME
    ROMPALO, AE
    SULE, RR
    TOLAT, SN
    JADHAV, VD
    QUINN, TC
    BOLLINGER, RC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) : 1486 - 1491
  • [10] Mehendale SM, 1996, INDIAN J MED RES, V104, P327